Söndag 18 Maj | 20:50:36 Europe / Stockholm
Svenska | English

Vimian Group

Bifogade filer

Kursutveckling under dagen för detta pressmeddelande (SEK).

Likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

Est. tid*
2025-10-22 07:50 Kvartalsrapport 2025-Q3
2025-07-18 07:50 Kvartalsrapport 2025-Q2
2025-04-30 - X-dag ordinarie utdelning VIMIAN 0.00 SEK
2025-04-29 - Årsstämma
2025-04-29 - Kvartalsrapport 2025-Q1
2025-02-13 - Bokslutskommuniké 2024
2024-10-24 - Kvartalsrapport 2024-Q3
2024-08-15 - Kvartalsrapport 2024-Q2
2024-05-23 - X-dag ordinarie utdelning VIMIAN 0.00 SEK
2024-05-22 - Årsstämma
2024-05-02 - Kvartalsrapport 2024-Q1
2024-02-15 - Bokslutskommuniké 2023
2023-11-08 - Kvartalsrapport 2023-Q3
2023-08-17 - Kvartalsrapport 2023-Q2
2023-06-02 - X-dag ordinarie utdelning VIMIAN 0.00 SEK
2023-06-02 - Årsstämma
2023-05-04 - Kvartalsrapport 2023-Q1
2023-03-24 - Extra Bolagsstämma 2023
2023-03-08 - Bokslutskommuniké 2022
2022-11-16 - Kvartalsrapport 2022-Q3
2022-10-03 - Extra Bolagsstämma 2022
2022-08-24 - Kvartalsrapport 2022-Q2
2022-06-03 - X-dag ordinarie utdelning VIMIAN 0.00 SEK
2022-06-02 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-03-09 - Bokslutskommuniké 2021
2021-11-26 - Kvartalsrapport 2021-Q3
2021-08-25 - Kvartalsrapport 2021-Q2

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriLäkemedel & Handel
Vimian Group är en koncern verksamma inom djurhälsa. Bolaget levererar via sina dotterbolag läkemedel och tekniska lösningar till veterinärer, laboratorier och husdjursägare. Produkterna inkluderar exempelvis läkemedel med tillhörande klinisk forskning samt digitala plattformar för veterinärkliniker. Bolaget är verksamma på en global nivå med huvudkontor i Stockholm.
Trading in Vimian Group AB (publ)’s ordinary shares on Nasdaq Stockholm commences today
2025-03-28 07:30:00

Vimian Group AB (publ) announces today the commencement of trading in the company’s ordinary shares on Nasdaq Stockholm.

"Today marks an important milestone for Vimian as we start trading on Nasdaq’s Main Market. Vimian has a history of delivering strong and profitable growth and is today a leader in select niches of the global animal health market. We continue to see significant potential ahead of us and are well positioned to accelerate value creation for our customers and shareholders around the world", says Patrik Eriksson, CEO of Vimian Group.

Vimian’s ordinary shares will be traded in the Large Cap segment with unchanged ticker (VIMIAN) and unchanged ISIN code (SE0015961982). There will be no offer or issuance of new shares in connection with the change of marketplace to Nasdaq Stockholm and shareholders in Vimian do not need to take any action in connection therewith.

Advokatfirman Vinge is acting as legal advisor to Vimian in connection with the listing on Nasdaq Stockholm.

For further information, please contact:

Maria Dahllöf Tullberg
Head of IR, Communications & Sustainability
maria.tullberg@vimian.com
+46 736 26 88 86

About Vimian

Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Veterinary Services and Diagnostics. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 17,000 veterinary clinics and laboratories, sells to over 80 markets, has 1,200 employees and annual revenues of approximately EUR 375 million. For more information, please visit: www.vimian.com.

Attachments

Trading in Vimian Group AB (publ)’s ordinary shares on Nasdaq Stockholm commences today

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden